The following article, New Moderna Vaccine Is Reportedly 94.5% Effective At Preventing COVID-19 Infection, was first published on Flag And Cross.
Moderna Inc. released a statement on Monday saying that it’s experimental coronavirus vaccine is 94.5 percent effective at preventing COVID-19 infections. This information is based on a set of interim data from late-stage clinical trials, making Moderna the second company in a week to report virus results that surpassed early projected expectations.
Along with the vaccine candidate from Pfizer Inc., which has a 90 percent rate of effectiveness, and pending more safety and regulatory reviews, we could see two vaccines authorized for immediate use in the month of December with something like 60 million doses ready by the end of the year.
Next year, the U.S. government could have access to more than 1 billion doses just from the two vaccine makers, more than needed for the country’s 330 million residents.
The vaccines, both built using new technology known as messenger RNA or mRNA, represent powerful new tools to fight a pandemic that has infected 54 million people worldwide and killed 1.3 million. The news also comes at time when COVID-19 cases are soaring, hitting new records in the United States and pushing some European countries back into lockdowns.
“We are going to have a vaccine that can stop COVID-19,” Moderna President Stephen Hoge said in a telephone interview.
Continue reading: New Moderna Vaccine Is Reportedly 94.5% Effective At Preventing COVID-19 Infection ...